Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.

Manhattanites are flocking to restaurants that are being compared to Applebee's and TGI Friday's in search of simple meals - ...

Dr. Daniel Drucker, an endocrinologist and a clinician-scientist at the University of Toronto and the Lunenfeld-Tanenbaum ...

CMS has published its final rule for Medicare Advantage and Part D in 2026, outlining a series of regulatory updates aimed at ...

A Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes ...

Proponents of coverage argued treating obesity can reduce longer-term costs by cutting down on heart attacks and other health ...

The most well known GLP-1 medication is Ozempic, though in Australia it is only approved for the management of Type 2 ...

Telehealth platform Hims & Hers Health, Inc. (HIMS), which connects consumers to healthcare professionals, is at a crossroads ...

Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment ...

Medically reviewed by Lindsay Cook, PharmD Weight loss medications can be an effective option for people struggling to lose ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...